Skip to main navigation Skip to search Skip to main content

Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18

  • M. Kim
  • , J. L. Lee
  • , S. J. Shin
  • , W. K. Bae
  • , H. J. Lee
  • , J. H. Byun
  • , Y. J. Choi
  • , J. Youk
  • , C. Y. Ock
  • , S. Kim
  • , H. Song
  • , K. H. Park
  • , B. Keam*
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

14   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry